SCHEMBL3471197

SCHEMBL3471197

O=C(Nc1ccccc1F)c1nnc(Nc2ccc(F)c(F)c2)o1

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 20/20 0.65
SOAT1 P35610 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3928136 0.88 DGAT1 (0.69) DGAT1SOAT1
SCHEMBL5247889 0.82 DGAT1 (0.55) DGAT1SOAT1
SCHEMBL3548447 0.82 DGAT1 (0.83) DGAT1SOAT1
SCHEMBL3542950 0.81 DGAT1 (0.79) DGAT1
SCHEMBL13946974 0.80 DGAT1 (0.54) DGAT1SOAT1
SCHEMBL15638678 0.80 DGAT1 (0.57) DGAT1SOAT1
SCHEMBL3541491 0.79 DGAT1 (1.00) DGAT1
SCHEMBL3544242 0.78 DGAT1 (0.85) DGAT1
SCHEMBL3545111 0.78 DGAT1 (0.68) DGAT1SOAT1
SCHEMBL5249259 0.78 DGAT1 (0.60) DGAT1SOAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010070343-A1 1,3,4-OXADIAZOLE DERIVATIVES AND THEIR USES TO TREAT DIABETES ASTRAZENECA AB (SE) 2010-06-24 WO disclosed